Abstract: Methods, systems, computer-readable media, and apparatuses for a magnetic resonance home unit are presented. In one embodiment, a method for using a magnetic resonance home unit includes opening a magnetic resonance application; accessing a magnetic resonance treatment protocol associated with a magnetic resonance treatment; and outputting the magnetic resonance treatment to a patient.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: The present invention is directed to methods for providing a polyelectrolyte multilayer film at a liquid-liquid interface. Such methods include steps of sequentially-depositing layers of cationic and anionic polyelectrolytes at a liquid-liquid interface that is formed between immiscible first and second liquids whereby a polyelectrolyte multilayer film is provided at the liquid-liquid interface. In certain preferred embodiments, the first liquid is an aqueous solution and the second liquid is a liquid crystal. In alternative embodiments, the first liquid is an aqueous solution and the second liquid is an oil. The invention further encompasses polyelectrolyte multilayer films provided by the disclosed methods as well as applications utilizing such materials.

Abstract: The present invention is directed to methods for providing a polyelectrolyte multilayer film at a liquid-liquid interface. Such methods include steps of sequentially-depositing layers of cationic and anionic polyelectrolytes at a liquid-liquid interface that is formed between immiscible first and second liquids whereby a polyelectrolyte multilayer film is provided at the liquid-liquid interface. In certain preferred embodiments, the first liquid is an aqueous solution and the second liquid is a liquid crystal. In alternative embodiments, the first liquid is an aqueous solution and the second liquid is an oil. The invention further encompasses polyelectrolyte multilayer films provided by the disclosed methods as well as applications utilizing such materials.

Abstract: The present invention is directed to methods for providing a polyelectrolyte multilayer film at a liquid-liquid interface. Such methods include steps of sequentially-depositing layers of cationic and anionic polyelectrolytes at a liquid-liquid interface that is formed between immiscible first and second liquids whereby a polyelectrolyte multilayer film is provided at the liquid-liquid interface. In certain preferred embodiments, the first liquid is an aqueous solution and the second liquid is a liquid crystal. In alternative embodiments, the first liquid is an aqueous solution and the second liquid is an oil. The invention further encompasses polyelectrolyte multilayer films provided by the disclosed methods as well as applications utilizing such materials.

Abstract: The present invention relates to improved therapeutically active nanocomposite microstructure compositions, including nanoparticle compositions and nanoparticle preparations. Preferred embodiments include nanoparticle compositions comprising nanoparticles of a therapeutically active agent dispersed in a carrier matrix. The invention also relates to a method for preparing said compositions and preparations using solid-state mechanochemical synthesis. Further, it relates to therapeutic products produced using said compositions and to methods of treatment using the compositions.

Abstract: The present invention is directed to methods for providing a polyelectrolyte multilayer film at a liquid-liquid interface. Such methods include steps of sequentially-depositing layers of cationic and anionic polyelectrolytes at a liquid-liquid interface that is formed between immiscible first and second liquids whereby a polyelectrolyte multilayer film is provided at the liquid-liquid interface. In certain preferred embodiments, the first liquid is an aqueous solution and the second liquid is a liquid crystal. In alternative embodiments, the first liquid is an aqueous solution and the second liquid is an oil. The invention further encompasses polyelectrolyte multilayer films provided by the disclosed methods as well as applications utilizing such materials.

Abstract: Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as an immediate release product as a single dose. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled-release matrix and released, over time, with the opioid.

Abstract: An altitude simulation system is disclosed for simulating an altitude within an enclosure or mask, wherein various improvements are provided, including: (a) a more effective use hypoxpic air generated by the system via recirculating techniques and improvements in air leakage, (b) improvements in determining when a simulated altitude is reached, (c) improvements in controlling hypoxic air generators so that peak electrical power loads are reduced and there are enhanced failsafe features for protecting the health of users, (d) using a pulse oximetry device for measuring oxygen saturation in a user's blood to thereby vary the oxygen content in the air provided to the user.

Abstract: A method for inducing analgesia and/or inhibiting abuse of abusive substances includes administration of d-methadone metabolites or their structural analogs. The d-methadone metabolites, EMDP and EDDP, and their structural analogs may be incorporated into a suitable pharmaceutical composition for administration to patients. The invention includes the method itself, certain structural analogs, and pharmaceutical compositions for use in accordance with the method.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: The invention relates to capsules coated with a polyelectrolyte shell and methods for the production thereof.

Abstract: Process for encapsulation of an uncharged crystalline solid particle include treating the crystalline solid particle material with amphiphilic substances and subsequently coating the material with a layer of charged polyelectrolyte or coating the material with a multilayer comprising alternating layers of oppositely charged polyelectrolytes.

Abstract: The invention relates to phase transfers of nanoparticles and to a catalysis using said nanoparticles. The aim of the invention is to facilitate a transfer of nanoparticles from an organic solution to an inorganic, especially, aqueous solution. To this end, a generically describable substance class, for example the commercially available 4-dimethylaminopyridine (DMAP), which is for example dissolved in water, is added to the organic solution in sufficient amounts. This measure has the effect that the nanoparticles are readily transferred in a one-step process from the organic phase (in each case in the top section) to the inorganic phase (in each case in the lower section) in the sample container.

Abstract: Methods, devices and device components are presented for reducing pathogenic biological contaminants in biological samples, in particular, methods, devices and device components for treating biological samples with electromagnetic radiation. In one aspect, the invention provides illuminators having differentially cooled light sources which exhibit improved light source longevity over conventional high intensity illuminators. In another aspect, the invention provides illuminators having closed loop feedback temperature control which produce radiant intensities and powers that are substantially constant as a function of time.